LYRA

Healthcare

Lyra Therapeutics, Inc.

$1.32-0.02 (-1.49%)

Prev Close

$1.34

Open

$1.32

High

$1.34

Low

$1.32

Volume

2.8K

Market Cap

$2.3M

P/E

—

Div Yield

—

Over the past 12 months, insider activity at Lyra Therapeutics, Inc. (LYRA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 6 insider sales totaling $36.7K. The most recent insider transaction was by Cavalier Jason (officer: Chief Financial Officer), who sold $2.6K worth of shares on Jan 8, 2026. Lyra Therapeutics, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $2.3M.

Buys (12M)

$0.00

Sells (12M)

$36.7K

Net Activity

Net Seller

$36.7K

Active Insiders

last 12 mo

LYRA Price Chart

LYRA Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jan 8, 2026↗	Cavalier Jason	officer: Chief Financial Officer	Sell	769	$3.36	$2.6K	518,547
Jan 8, 2026↗	Palasis Maria	director, officer: President & CEO	Sell	1,702	$3.36	$5.7K	1,096,730
Jan 6, 2026↗	Cavalier Jason	Chief Financial Officer	Sell	769	$3.36	$2.6K	0
Jan 6, 2026↗	Palasis Maria	President & CEO	Sell	1,702	$3.36	$5.7K	0
Jul 10, 2025↗	Cavalier Jason	Chief Financial Officer	Sell	684	$8.91	$6.1K	0
Jul 10, 2025↗	Palasis Maria	President & CEO	Sell	1,565	$8.91	$13.9K	0
Nov 13, 2023↗	Waksal Harlan	Executive Chair	Buy	25,000	$2.96	$74.1K	261,966
Jun 2, 2023↗	ANDERSON EDWARD T	Director	Buy	2,708,124	$1.66	$4.50M	2,521,740
Jun 2, 2023↗	NBVM GP, LLC	10% Owner	Buy	2,708,124	$1.66	$4.50M	2,521,740
Jun 2, 2023↗	PERCEPTIVE ADVISORS LLC	Director	Buy	3,610,832	$2.49	$9.00M	11,469,100
Jun 13, 2022↗	MERRIFIELD C ANN	Director	Buy	4,000	$5.05	$20.2K	11,328
May 17, 2022↗	MERRIFIELD C ANN	Director	Buy	3,828	$4.83	$18.5K	7,328
Apr 14, 2022↗	ANDERSON EDWARD T	Director	Buy	2,488,150	$4.22	$10.50M	1,855,440
Apr 14, 2022↗	NBVM GP, LLC	10% Owner	Buy	2,369,667	$4.22	$10.00M	1,855,440
Apr 14, 2022↗	PERCEPTIVE ADVISORS LLC	Director	Buy	5,924,170	$4.22	$25.00M	7,858,280
Apr 13, 2022↗	Waksal Harlan	Executive Chair	Buy	236,966	$4.22	$1000.0K	236,966
Jun 22, 2021↗	MERRIFIELD C ANN	Director	Buy	3,500	$8.97	$31.4K	3,500

LYRA Insider Buying Activity

The following table shows recent insider purchases of Lyra Therapeutics, Inc. (LYRA) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Nov 13, 2023↗	Waksal Harlan	Executive Chair	Buy	25,000	$2.96	$74.1K	261,966
Jun 2, 2023↗	ANDERSON EDWARD T	Director	Buy	2,708,124	$1.66	$4.50M	2,521,740
Jun 2, 2023↗	NBVM GP, LLC	10% Owner	Buy	2,708,124	$1.66	$4.50M	2,521,740
Jun 2, 2023↗	PERCEPTIVE ADVISORS LLC	Director	Buy	3,610,832	$2.49	$9.00M	11,469,100
Jun 13, 2022↗	MERRIFIELD C ANN	Director	Buy	4,000	$5.05	$20.2K	11,328
May 17, 2022↗	MERRIFIELD C ANN	Director	Buy	3,828	$4.83	$18.5K	7,328
Apr 14, 2022↗	ANDERSON EDWARD T	Director	Buy	2,488,150	$4.22	$10.50M	1,855,440
Apr 14, 2022↗	NBVM GP, LLC	10% Owner	Buy	2,369,667	$4.22	$10.00M	1,855,440
Apr 14, 2022↗	PERCEPTIVE ADVISORS LLC	Director	Buy	5,924,170	$4.22	$25.00M	7,858,280
Apr 13, 2022↗	Waksal Harlan	Executive Chair	Buy	236,966	$4.22	$1000.0K	236,966
Jun 22, 2021↗	MERRIFIELD C ANN	Director	Buy	3,500	$8.97	$31.4K	3,500

LYRA Insider Selling Activity

The following table shows recent insider sales of Lyra Therapeutics, Inc. (LYRA) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Jan 8, 2026↗	Cavalier Jason	officer: Chief Financial Officer	Sell	769	$3.36	$2.6K	518,547
Jan 8, 2026↗	Palasis Maria	director, officer: President & CEO	Sell	1,702	$3.36	$5.7K	1,096,730
Jan 6, 2026↗	Cavalier Jason	Chief Financial Officer	Sell	769	$3.36	$2.6K	0
Jan 6, 2026↗	Palasis Maria	President & CEO	Sell	1,702	$3.36	$5.7K	0
Jul 10, 2025↗	Cavalier Jason	Chief Financial Officer	Sell	684	$8.91	$6.1K	0
Jul 10, 2025↗	Palasis Maria	President & CEO	Sell	1,565	$8.91	$13.9K	0